JPMorgan lowers CVS Health (NYSE:CVS) price target from $125 to $114By legume / May 31, 2023 / CVS Health, JPMorgan JPMorgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $125 to $114.